Alkem Laboratories received an income tax order dated April 13, 2026, disputing ₹333.38 Crores for AY 2023-24.
The order disallowed part of a Section 80IE deduction and made transfer pricing adjustments.
The company states no cash outflow is expected due to available MAT credit utilization.
Alkem will appeal the order, believing it has adequate factual and legal grounds.